Insider · CIK 0001712276

Taylor Ben R

Reports to the SEC for 2 companies · SALT LAKE CITY, UT

sec.gov

Transactions

Companies

Filings

CIK

0001712276

Forms 4 and 5

Insider transactions

38 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-15	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−5,396 sh	$3.41	−$18.4K	1,071,462
2026-08-17	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−25K sh	$3.16	−$79.1K	1,076,858
2026-06-15	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−5,396 sh	$3.15	−$17K	1,101,876
2026-05-15	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−25K sh	$3.04	−$76.1K	1,107,272
2026-04-06	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−48K sh	$3.11	−$149K	1,132,290
2026-03-17	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Chief Financial Officer	SSale	−7,956 sh	$3.39	−$27K	1,180,318
2026-03-16	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−7,075 sh	$3.42	−$24.2K	1,188,274
2026-02-18	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Chief Financial Officer	SSale	−13.4K sh	$3.08	−$41.4K	1,195,349
2026-02-17	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−11.9K sh	$3.49	−$41.6K	1,208,775
2026-02-06	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Chief Financial Officer	AAward	+446K sh	—	—	1,207,829
2026-02-06	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Chief Financial Officer	AAward	+24.3K sh	—	—	1,232,083
2026-02-06	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−11.4K sh	$3.98	−$45.4K	1,220,683
2025-12-29	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Chief Financial Officer	SSale	−21.4K sh	$4.18	−$89.4K	761,550
2025-12-15	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−7,057 sh	$4.33	−$30.6K	782,933
2025-11-25	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−2,271 sh	$4.03	−$9,152.13	789,990
2025-11-17	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−11.9K sh	$4.14	−$49.3K	792,261
2025-09-15	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−7,057 sh	$4.83	−$34.1K	804,169
2025-08-15	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−11.9K sh	$5.64	−$67.2K	811,226
2025-06-16	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−7,057 sh	$4.92	−$34.7K	823,134
2025-05-15	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−11.9K sh	$4.25	−$50.6K	830,191
2025-04-01	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−26.6K sh	$5.09	−$135K	842,099
2025-03-17	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−7,057 sh	$6.84	−$48.3K	868,670
2025-02-18	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−10.9K sh	$10.64	−$116K	875,727
2025-02-03	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Chief Financial Officer	AAward	+35K sh	—	—	879,228
2025-02-03	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Chief Financial Officer	AAward	+13.9K sh	—	—	893,150
2025-02-03	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−6,544 sh	$7.25	−$47.4K	886,606
2025-02-03	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+70K sh	—	—	70,037
2024-12-19	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Chief Financial Officer	AAward	+370K sh	—	—	844,210
2024-12-19	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+741K sh	—	—	740,686
2024-12-17	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−7,057 sh	$6.95	−$49K	473,867
2024-12-16	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−15.7K sh	$6.04	−$94.6K	480,924
2020-05-07	TYME TECHNOLOGIES, INC.Employee Stock Option - right to buyA Award	President, CFO	AAward	+360K sh	—	—	360,000
2019-06-14	TYME TECHNOLOGIES, INC.P Purchase	President, CFO	PPurchase	+10K sh	$1.01	+$10.1K	10,000
2019-05-03	TYME TECHNOLOGIES, INC.Employee Stock Option - right to buyA Award	President, CFO	AAward	+469K sh	—	—	469,300
2018-06-30	TYME TECHNOLOGIES, INC.Employee Stock Option - right to buyA Award	President, CFO	AAward	+1.5M sh	—	—	1,500,000
2018-05-24	TYME TECHNOLOGIES, INC.Employee Stock Option - right to buyA Award	President, CFO	AAward	+400K sh	—	—	400,000
2017-11-22	TYME TECHNOLOGIES, INC.Employee Stock Option - right to buyA Award	President, CFO	AAward	+50K sh	—	—	50,000
2017-11-22	TYME TECHNOLOGIES, INC.Employee Stock Option - right to buyA Award	President, CFO	AAward	+130K sh	—	—	129,957

Recent filings

Accepted (ET)
Sep 164
Taylor Ben R0001601830-26-000110
SEC(opens sec.gov)
Aug 184
Taylor Ben R0001712276-26-000009
SEC(opens sec.gov)
Jun 174
Taylor Ben R0001712276-26-000007
SEC(opens sec.gov)
May 194
Taylor Ben R0001712276-26-000005
SEC(opens sec.gov)
Apr 84
Taylor Ben R0001712276-26-000003
SEC(opens sec.gov)
Mar 184
Taylor Ben R0001712276-26-000002
SEC(opens sec.gov)
Feb 194
Taylor Ben R0001601830-26-000020
SEC(opens sec.gov)
Feb 104
Taylor Ben R0001601830-26-000013
SEC(opens sec.gov)
Dec 304
Taylor Ben R0001712276-25-000017
SEC(opens sec.gov)
Dec 174
Taylor Ben R0001712276-25-000015
SEC(opens sec.gov)
Nov 264
Taylor Ben R0001712276-25-000013
SEC(opens sec.gov)
Nov 194
Taylor Ben R0001712276-25-000011
SEC(opens sec.gov)
Sep 174
Taylor Ben R0001601830-25-000147
SEC(opens sec.gov)
Aug 194
Taylor Ben R0001601830-25-000133
SEC(opens sec.gov)
Jun 184
Taylor Ben R0001601830-25-000091
SEC(opens sec.gov)
May 194
Taylor Ben R0001601830-25-000083
SEC(opens sec.gov)

Companies

Address

41 S. RIO GRANDE STREET

SALT LAKE CITY, UT, 84101